ArticleJTO clinical and research reports2022

Phase 3 Trial of BI 695502 Plus Chemotherapy Versus Bevacizumab Reference Product Plus Chemotherapy in Patients With Advanced Nonsquamous NSCLC.

Edward S Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.